Genocea Biosciences Inc (NASDAQ:GNCA) shares are surging nicely ahead 8% today after the firm hosted an R&D day yesterday via a webinar providing …
Pacific Biosciences of California (NASDAQ:PACB) shares are on a 42% nosedive after announcing this morning before market open that Roche has terminated its collaboration …
Brean Capital analyst Fawne Jiang is confident on Baidu Inc (ADR) (NASDAQ:BIDU) after hosting a group investor conference call yesterday with Linda Sun …
Cowen analyst John Blackledge is all the more bullish on Netflix, Inc. (NASDAQ:NFLX) following CEO of Charter Tom Rutledge’s recent comments at an …
Yesterday morning, Amazon.com, Inc.
Achaogen Inc (NASDAQ:AKAO) shares rose 14% today after the company reported positive top-line results from the phase 3 trial of its treatment for urinary …
During last week’s American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, bluebird bio Inc (NASDAQ:BLUE) provided clinical updates on …
OHR Pharmaceutical Inc (NASDAQ:OHRP) is confronting the aftermath of Fovista’s pivotal two Phase 3 failures that both missed the primary endpoint in neovascular …
In a research report published Monday, H.C.
Horizon Pharma PLC (NASDAQ:HZNP) has had a recent misstep on its hands with a Phase 3 flop in its Actimmune Friedrich’s Ataxia (FA) …